<DOC>
	<DOCNO>NCT00384865</DOCNO>
	<brief_summary>The purpose study determine whether aspirin simvastatin safe effective treatment pulmonary arterial hypertension ( PAH ) .</brief_summary>
	<brief_title>A Study Aspirin Simvastatin Pulmonary Arterial Hypertension</brief_title>
	<detailed_description>PAH characterize dyspnea , fatigue , low extremity edema result heart failure . In PAH , situ thrombosis may occur lung , pulmonary endothelial dysfunction well-recognized . As aspirin inhibits platelet aggregation , may value use aspirin treat PAH . Simvastatin beneficial effect blood vessel type cardiovascular disease . Therefore , simvastatin may similarly benefit patient PAH . Participants study randomly assign receive 6 month daily placebo tablet , daily aspirin daily placebo , daily simvastatin daily placebo , daily aspirin daily simvastatin double-blind fashion . The study compare safety efficacy aspirin placebo simvastatin placebo .</detailed_description>
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Familial Primary Pulmonary Hypertension</mesh_term>
	<mesh_term>Hypertension , Pulmonary</mesh_term>
	<mesh_term>Aspirin</mesh_term>
	<mesh_term>Simvastatin</mesh_term>
	<criteria>Mean pulmonary artery pressure great 25 mm Hg rest pulmonary capillary wedge pressure le 16 mm Hg Diagnosis PAH ) idiopathic , b ) familial , c ) associate collagen vascular disease , HIV infection , congenital systemictopulmonary shunt , former anorexigen use Most recent pulmonary function test show FEV1/FVC ratio great 50 % AND one follow condition : ) total lung capacity great 70 % predict , b ) total lung capacity 60 % 70 % predict value mild patchy interstitial lung disease high resolution computerize tomography chest Ability perform sixminute walk test without limitation musculoskeletal function coordination Negative pregnancy test screen visit woman childbearing potential If female , willing use adequate form birth control PAH related etiology Diagnosis sickle cell disease Clinically significant untreated sleep apnea , diagnose polysomnography Leftsided valvular disease ( moderate mitral valve stenosis insufficiency aortic stenosis insufficiency ) , pulmonary artery valve stenosis , ejection fraction le 45 % echocardiography Hospitalized acutely ill Kidney failure Initiation PAH therapy ( prostacyclin analogue , endothelin [ ET ] 1 receptor antagonist , phosphodiesterase [ PDE ] 5 inhibitor ) within 3 month study entry Allergy hypersensitivity aspirin simvastatin Absolute indication aspirin antiplatelet therapy Current treatment statin therapy Inability unwillingness avoid nonsteroidal , antiinflammatory medication 6 month follow study entry Current recent use plan treatment one following : amiodarone , cyclosporine , itraconazole , ketoconazole , erythromycin , clarithromycin , HIV protease inhibitor , nefazodone , cimetidine , danazol , large quantity grapefruit juice ( 1 quart daily ) , verapamil , fibrates , niacin Peptic duodenal ulcer diagnose within 1 year study entry Gastrointestinal bleeding within 6 month prior study entry Bleeding diathesis History intracranial bleeding Anemia ( hematocrit le 30 % ) screen International normalized ratio ( INR ) great 3.0 screen Severe thrombocytopenia ( le 75,000/L ) screen Hepatic transaminase great twice upper limit normal screen Chronic liver disease ( e.g. , cirrhosis , chronic hepatitis ) portal hypertension Current recent ( within 6 month study entry ) chronic heavy alcohol consumption History myositis Creatine phosphokinase ( CPK ) great 1.5 time upper limit normal screen Abnormalities arm hand past radical mastectomy might prevent brachial artery ultrasound Pregnant breastfeeding Current use another investigational drug PAH Received lung transplant</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2009</verification_date>
	<keyword>Pulmonary Arterial Hypertension</keyword>
</DOC>